What is the treatment for a basilar tip (cerebral) aneurism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Basilar Tip Aneurysms

Ruptured Basilar Tip Aneurysms

For ruptured basilar tip aneurysms amenable to endovascular treatment, coiling is preferred over surgical clipping to improve outcomes. 1

Treatment Algorithm for Ruptured Aneurysms

  • Endovascular coiling is the first-line treatment for ruptured basilar tip aneurysms that are anatomically suitable for this approach 1
  • The American Heart Association recommends complete obliteration of the aneurysm whenever possible to reduce complications 1
  • Multidisciplinary decision-making involving both experienced cerebrovascular surgeons and endovascular specialists should determine the optimal treatment approach 1

Specific Patient Populations Favoring Coiling

  • Elderly patients (>70 years) benefit more from endovascular coiling than surgical clipping 1
  • Poor-grade SAH patients (WFNS IV/V) should preferentially receive coiling 1
  • Basilar apex aneurysms specifically are better treated with coiling due to their anatomical location 1

When Surgical Clipping May Be Preferred

  • Patients with large intraparenchymal hematomas (>50 mL) requiring evacuation may benefit from surgical clipping 1
  • However, basilar tip location generally favors endovascular approach even in these circumstances 1

Unruptured Basilar Tip Aneurysms

Treatment decisions for unruptured basilar tip aneurysms must weigh the high surgical risk of posterior circulation aneurysms against rupture risk, with strong consideration for treatment in symptomatic aneurysms and those ≥10mm. 2

Size-Based Treatment Recommendations

  • Aneurysms ≥10mm warrant strong consideration for treatment, accounting for patient age, medical condition, and treatment risks 2
  • Small aneurysms (<10mm) in patients without prior SAH generally cannot be advocated for treatment over observation, though special considerations apply 2
  • Basilar apex aneurysms carry relatively high rupture risk regardless of size and deserve special consideration for treatment 2

Symptomatic Unruptured Aneurysms

  • All symptomatic intradural aneurysms should be considered for treatment with relative urgency for acutely symptomatic cases 2
  • Symptoms from mass effect on brainstem structures, cranial nerve compression, or ischemic phenomena can be effectively treated with intervention 2
  • Symptomatic large or giant aneurysms carry higher treatment risks requiring careful risk-benefit analysis 2

Special Considerations for Basilar Tip Location

  • Basilar tip aneurysms are intimately associated with midbrain perforating arteries, which can be injured during open surgery 2
  • Posterior circulation aneurysms historically carry higher surgical risk than anterior circulation, particularly giant aneurysms (mortality 9.6%, morbidity 37.9%) 2
  • Endovascular coiling shows lower permanent complication rates (5-9% permanent deficits) compared to surgical approaches for basilar tip aneurysms 2

Endovascular Treatment Specifics

Coil Embolization Outcomes

  • Technical success rates approach 100% for basilar tip aneurysms treated with coiling 3
  • Complete occlusion achieved in 67-94% of cases initially 3, 4
  • Annual rebleeding rate after coiling is 0.3% for basilar tip aneurysms during long-term follow-up 4
  • Procedural mortality is 2.7% with permanent stroke deficits in 5-9% of patients 2

Limitations and Follow-up Requirements

  • Incomplete obliteration occurs in 46% of coiled aneurysms overall, though basilar tip-specific rates are lower 2
  • Aneurysm reopening occurs in 17.5% of basilar tip aneurysms during follow-up, with large/giant aneurysms (>10mm) having 7-fold higher risk requiring re-treatment 4
  • Mandatory angiographic follow-up is required to detect reopening, especially in large and giant aneurysms 4
  • Posterior cerebral artery occlusion occurs in 24% of cases, though only 5% develop permanent neurologic deficits 3

Technical Considerations

  • Stent-assisted coiling required in 26-71% of basilar tip aneurysms depending on neck morphology 5, 4
  • WEB device embolization requires stent assistance less frequently (2.5% vs 71%) compared to conventional coiling for wide-necked aneurysms 5
  • Treatment duration is shorter with WEB devices compared to conventional coiling 5

Age-Related Treatment Decisions

  • Patients <45 years: 6.5% combined morbidity/mortality with surgical treatment 2
  • Patients 45-65 years: 14.4% combined morbidity/mortality 2
  • Patients >64 years: 32% combined morbidity/mortality with surgical approaches 2
  • Older age favors conservative management due to shorter life expectancy and higher treatment risks 2

Factors Favoring Treatment vs Observation

Favoring Treatment

  • Young patients with long life expectancy 2
  • Previously ruptured aneurysms elsewhere (higher rupture risk) 2
  • Family history of aneurysm rupture 2
  • Observed aneurysm growth on serial imaging 2
  • Symptomatic aneurysms causing mass effect or neurologic symptoms 2

Favoring Observation

  • Older patient age with limited life expectancy 2
  • Small size (<10mm) in asymptomatic patients without prior SAH 2
  • Significant medical comorbidities increasing treatment risk 2

Critical Pitfalls to Avoid

  • Do not assume all basilar tip aneurysms require treatment - small asymptomatic aneurysms in elderly patients may have higher treatment risk than rupture risk 2
  • Hospital volume matters significantly - mortality is 53% lower at centers performing >10 aneurysm procedures annually (5.3% vs 11.2%) 2
  • Incomplete coil embolization requires vigilant follow-up as its effect on bleeding rate remains unclear 2
  • Stenting of ruptured aneurysms increases morbidity and mortality and should be avoided when possible 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.